Pharmacokinetics of oseltamivir carboxylate in critically ill patients: each patient is unique.
作者信息
Kromdijk W, Sikma M A, van den Broek M P H, Beijnen J H, Huitema A D R, de Lange D W
出版信息
Intensive Care Med. 2013 May;39(5):977-8. doi: 10.1007/s00134-013-2851-x. Epub 2013 Feb 27.
Abstract
摘要
相似文献
1
Pharmacokinetics of oseltamivir carboxylate in critically ill patients: each patient is unique.
Intensive Care Med. 2013 May;39(5):977-8. doi: 10.1007/s00134-013-2851-x. Epub 2013 Feb 27.
2
Pharmacokinetics of oseltamivir and oseltamivir carboxylate in critically ill patients receiving continuous venovenous hemodialysis and/or extracorporeal membrane oxygenation.
Pharmacotherapy. 2012 Dec;32(12):1061-9. doi: 10.1002/phar.1151.
3
Impact of extracorporeal membrane oxygenation and continuous venovenous hemodiafiltration on the pharmacokinetics of oseltamivir carboxylate in critically ill patients with pandemic (H1N1) influenza.
Ther Drug Monit. 2012 Apr;34(2):171-5. doi: 10.1097/FTD.0b013e318248672c.
4
Oseltamivir pharmacokinetics in critically ill adults receiving extracorporeal membrane oxygenation support.
Anaesth Intensive Care. 2013 Jan;41(1):66-73. doi: 10.1177/0310057X1304100112.
5
Oseltamivir carboxylate accumulation in a patient treated by haemodiafiltration and extracorporeal membrane oxygenation.
Intensive Care Med. 2010 Jul;36(7):1273-4. doi: 10.1007/s00134-010-1882-9. Epub 2010 Apr 8.
6
Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.
Clin Pharmacokinet. 2010 Nov;49(11):741-65. doi: 10.2165/11534730-000000000-00000.
7
Oseltamivir dosing for influenza infection in premature neonates.
J Infect Dis. 2010 Aug 15;202(4):563-6. doi: 10.1086/654930.
8
Pharmacokinetics of oseltamivir according to trimester of pregnancy.
Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S89-93. doi: 10.1016/j.ajog.2011.03.005. Epub 2011 Mar 9.
9
Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A.
J Antimicrob Chemother. 2011 May;66(5):1140-9. doi: 10.1093/jac/dkq511. Epub 2011 Jan 7.
10
Route of Oseltamivir Administration Affects Metabolite Concentrations in Critically Ill Children.
Pediatr Infect Dis J. 2019 Dec;38(12):1224-1227. doi: 10.1097/INF.0000000000002473.
引用本文的文献
1
Influenza and Aging: Clinical Manifestations, Complications, and Treatment Approaches in Older Adults.
Drugs Aging. 2025 Jan;42(1):39-55. doi: 10.1007/s40266-024-01169-y. Epub 2025 Jan 7.
2
Influenza virus-related critical illness: prevention, diagnosis, treatment.
Crit Care. 2019 Jun 12;23(1):214. doi: 10.1186/s13054-019-2491-9.
3
Pharmacokinetics of Oral and Intravenous Oseltamivir Treatment of Severe Influenza B Virus Infection Requiring Organ Replacement Therapy.
Eur J Drug Metab Pharmacokinet. 2017 Feb;42(1):155-164. doi: 10.1007/s13318-016-0330-9.
4
Designing drug regimens for special intensive care unit populations.
World J Crit Care Med. 2015 May 4;4(2):139-51. doi: 10.5492/wjccm.v4.i2.139.
5
A part-randomized study of intravenous oseltamivir in adolescents and adults.
Eur J Clin Microbiol Infect Dis. 2015 Jun;34(6):1181-8. doi: 10.1007/s10096-015-2338-5. Epub 2015 Feb 13.
6
Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial.
Intensive Care Med. 2014 Mar;40(3):380-7. doi: 10.1007/s00134-013-3187-2. Epub 2013 Dec 20.
本文引用的文献
1
Quantitative determination of oseltamivir and oseltamivir carboxylate in human fluoride EDTA plasma including the ex vivo stability using high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Apr 1;891-892:57-63. doi: 10.1016/j.jchromb.2012.02.026. Epub 2012 Feb 23.
2
Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.
Clin Pharmacokinet. 2010 Nov;49(11):741-65. doi: 10.2165/11534730-000000000-00000.
3
Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza.
CMAJ. 2010 Mar 9;182(4):357-63. doi: 10.1503/cmaj.092127. Epub 2010 Feb 16.
4
Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.
Clin Pharmacokinet. 2005;44(10):989-1008. doi: 10.2165/00003088-200544100-00001.
Zotero 插件